Dow Jones

38,807.33

0.25%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Serono (SRA)

Serono S A

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:SRA

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
17/01/2011	08:32	PR Newswire (US)	Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's Disease	NYSE:SRA	Serono S A
12/01/2011	08:01	PR Newswire (US)	Brighter Futures in MS - Inspiring Short Film Premieres in Brussels	NYSE:SRA	Serono S A
13/12/2010	11:00	PR Newswire (US)	Merck Serono and San Raffaele Scientific Institute to Collaborate on Research in Neurodegenerative Diseases	NYSE:SRA	Serono S A
26/11/2010	07:00	PR Newswire (US)	Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Mu	NYSE:SRA	Serono S A
17/11/2010	07:46	PR Newswire (US)	Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MS	NYSE:SRA	Serono S A
15/11/2010	07:30	PR Newswire (US)	Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in Europe	NYSE:SRA	Serono S A
04/11/2010	06:00	PR Newswire (US)	Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson's	NYSE:SRA	Serono S A
28/10/2010	15:33	PR Newswire (US)	Merck Serono Sells Théramex to Teva for EUR 265 Million	NYSE:SRA	Serono S A
25/10/2010	10:19	PR Newswire (US)	Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of	NYSE:SRA	Serono S A
15/10/2010	14:30	PR Newswire (US)	Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple Sclerosis	NYSE:SRA	Serono S A
13/10/2010	08:00	PR Newswire (US)	Merck Serono: New Presentation of Cyanokit(R) Approved in Europe	NYSE:SRA	Serono S A
11/10/2010	07:00	PR Newswire (US)	Merck Serono Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MS	NYSE:SRA	Serono S A
11/10/2010	06:30	PR Newswire (US)	Ablynx and Merck Serono Enter into Second Agreement To Co-Discover and Co-Develop Nanobodies (R)	NYSE:SRA	Serono S A
03/08/2010	11:38	PR Newswire (US)	Merck Serono Calls for Entries to Real MS - Your Story, a Global Competition to Raise Awareness of Multiple Sclerosis	NYSE:SRA	Serono S A
28/07/2010	08:05	PR Newswire (US)	Merck Serono: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS	NYSE:SRA	Serono S A
12/07/2010	07:00	PR Newswire (US)	Merck Serono's Cladribine Tablets for MS Approved in Russia	NYSE:SRA	Serono S A
29/06/2010	07:00	PR Newswire (US)	Merck Serono to Award Grant to Innovative Research Projects in Fertility	NYSE:SRA	Serono S A
10/06/2010	06:30	PR Newswire (US)	Merck Serono: Data on Safinamide to Be Presented at the 14th MDS Meeting	NYSE:SRA	Serono S A
08/06/2010	07:00	PR Newswire (US)	Merck Serono Resubmits U.S. Application for Cladribine Tablets as a Potential MS Therapy	NYSE:SRA	Serono S A
26/05/2010	09:00	PR Newswire (US)	Your Story, Your Voice, Your Achievements, Your Ideas ... This Is About Life, Real Life, Real MS	NYSE:SRA	Serono S A
25/05/2010	08:07	PR Newswire (US)	International Thyroid Awareness Week 2010 to Focus on Thyroid Disorders and Pregnancy	NYSE:SRA	Serono S A
31/03/2010	08:00	PR Newswire (US)	Data from Merck Serono's Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of Neur	NYSE:SRA	Serono S A
10/10/2008	06:00	PR Newswire (US)	Merck Serono Named as a Top Employer by Science Magazine	NYSE:SRA
06/07/2007	10:01	PR Newswire (US)	Squeeze Out of Merck Serono Shares Successfully Completed	NYSE:SRA
26/04/2007	23:56	PR Newswire (US)	HealthShares(TM) Announces Changes to the HealthShares(TM) Dermatology & Wound Care, Emerging Cancer, and Composite Indexes	NYSE:SRA	Serono S A
05/04/2007	16:00	PR Newswire (US)	Merck Serono S.A. to Voluntarily Delist and Deregister its Bearer Shares and American Depositary Shares (Evidenced by American D	NYSE:SRA	Serono S A
21/03/2007	10:08	PR Newswire (US)	Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.	NYSE:SRA
21/03/2007	07:15	PR Newswire (US)	Merck Serono Confirms Previously Announced 2006 Figures	NYSE:SRA
01/03/2007	06:15	PR Newswire (US)	Merck KGaA Announces Serono Preliminary Figures for 2006	NYSE:SRA
28/02/2007	09:54	PR Newswire (US)	Merck Serono S.A. Preliminary Q4/FY 06 Results - March 1	NYSE:SRA	Serono S A